CoChat

Crosstalk between the Gut Microbiome and Colonic Motility in Chronic Constipation: Potential Mechanisms and Microbiota Modulation

Open access

The DOI matches its Crossref record; 164 of the 166 references it cites were found in a registry or an index.

Abstract

Chronic constipation (CC) is a highly prevalent and burdensome gastrointestinal disorder. Accumulating evidence highlights the link between imbalances in the gut microbiome and constipation. However, the mechanisms by which the microbiome and microbial metabolites affect gut movement remain poorly understood. In this review, we discuss recent studies on the alteration in the gut microbiota in patients with CC and the effectiveness of probiotics in treating gut motility disorder. We highlight the mechanisms that explain how the gut microbiome and its metabolism are linked to gut movement and how intestinal microecological interventions may counteract these changes based on the enteric nervous system, the central nervous system, the immune function, and the ability to modify intestinal secretion and the hormonal milieu. In particular, microbiota-based approaches that modulate the levels of short-chain fatty acids and tryptophan catabolites or that target the 5-hydroxytryptamine and Toll-like receptor pathways may hold therapeutic promise. Finally, we discuss the existing limitations of microecological management in treating constipation and suggest feasible directions for future research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu14183704

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mechanisms by which the microbiome and metabolites modulate the physiology of constipation. The gut microbiome and its metabolism impact host GI functions via regulation of the ENS, the CNS, the immune system, intestinal secretion, and the hormonal milieu. Notably, microbial-derived SCFAs and indole serve as ligands of 5-HTRs, TLRs, and AHR in the host, thereby facilitating microbiota-mediated functions. For example, the gut microbiome can influence TLR signaling, thereby mediating subsets of enteric neurons and gastrointestinal motility. The metabolite indole activates AHR to maintain mucosal immunity and homeostasis and 5-HT4R to increase colonic fluid secretion and accelerate gastrointestinal transit. Abbreviations: AHR, aryl hydrocarbon receptor; cAMP, cyclic AMP; CFTR, cystic fibrosis transmembrane regulator; ChAT, choline acetyltransferase; CNS, central nervous system; ENS, enteric nervous system; ER, estrogen receptor; GDNF, glial cell-derived neurotrophic factor; GLP-1, glucagon-like peptide-1; GPER, G protein coupled estrogen receptor; LPS, lipopolysaccharide; P4R, progesterone receptors; MCT2, monocarboxylate transporter 2; SCFAs, short-chain fatty acids; SERT, serotonin-selective reuptake transporter; Trp, Tryptophan; TPH1, tryptophan hydroxylase 1; Trpa1, transient receptor potential ankyrin A1; 5-HT, serotonin; TLR, Toll-like receptor; 5-HTP, 5-hydroxytryptophan.
Figure 1 Mechanisms by which the microbiome and metabolites modulate the physiology of constipation. The gut microbiome and its metabolism impact host GI functions via regulation of the ENS, the CNS, the immune system, intestinal secretion, and the hormonal milieu. Notably, microbial-derived SCFAs and indole serve as ligands of 5-HTRs, TLRs, and AHR in the host, thereby facilitating microbiota-mediated functions. For example, the gut microbiome can influence TLR signaling, thereby mediating subsets of enteric neurons and gastrointestinal motility. The metabolite indole activates AHR to maintain mucosal immunity and homeostasis and 5-HT4R to increase colonic fluid secretion and accelerate gastrointestinal transit. Abbreviations: AHR, aryl hydrocarbon receptor; cAMP, cyclic AMP; CFTR, cystic fibrosis transmembrane regulator; ChAT, choline acetyltransferase; CNS, central nervous system; ENS, enteric nervous system; ER, estrogen receptor; GDNF, glial cell-derived neurotrophic factor; GLP-1, glucagon-like peptide-1; GPER, G protein coupled estrogen receptor; LPS, lipopolysaccharide; P4R, progesterone receptors; MCT2, monocarboxylate transporter 2; SCFAs, short-chain fatty acids; SERT, serotonin-selective reuptake transporter; Trp, Tryptophan; TPH1, tryptophan hydroxylase 1; Trpa1, transient receptor potential ankyrin A1; 5-HT, serotonin; TLR, Toll-like receptor; 5-HTP, 5-hydroxytryptophan.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 154

Metadata

Authors
Pan, R., Wang, L., Xu, X., Chen, Y., Wang, H., Wang, G., Zhao, J., & Chen, W.
Affiliations
  • Jiangnan University (CN)
  • Wuxi People's Hospital (CN)
Corresponding author
  • Wang, Haojue
  • Zhao, Jianxin
Venue
Nutrients
Publisher
MDPI AG
Published
2022-09-08
Volume
14
Issue
18
Pages
3704
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4296117667
Cited by
149
References
166
Citations by year
2026: 33 · 2025: 55 · 2024: 41 · 2023: 17 · 2022: 3
FWCI
5.96
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • the National Natural Science Foundation of China (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
  • Fundamental Research Funds for the Central Universities (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
  • Program of Collaborative Innovation Centre of Food Safety and Quality Control in Jiangsu Province (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
  • Scientific Research Project Plan of Wuxi Municipal Health Commission (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
  • Wuxi Science and Technology Plan Project (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
  • Top Talent Support Program for Young and Middle-aged People of Wuxi Health Committee (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
  • Appropriate Technology Promotion Project of Wuxi Municipal Health Commission (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
  • Innovation Nurturing Fund project of Wuxi Xishan People’s Hospital (32172213, 31972052, 32021005, 31820103010, JUSRP22006, JUSRP51501, M202007, 2020X018, bj2020111, FYTG202006, Y202104)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
chronic constipation, gut microbiota, colonic motility, probiotics, short-chain fatty acids, tryptophan catabolites, serotonin, Toll-like receptors, enteric nervous system, gut-brain-immune axis, intestinal secretion, microbiota modulation
MeSH terms
Gastrointestinal Microbiome, Constipation, Fatty Acids, Volatile, Humans, Serotonin, Tryptophan, Toll-Like Receptors, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.